Peptide Bioregulators: The Lesser-Known Branch of Peptide Research
When most people hear the word peptide, they think of compounds such as BPC-157, GHK-Cu, TB-500, or growth-hormone-related peptides.
But there’s another category that operates under a very different research framework: peptide bioregulators.
These compounds are associated primarily with decades of work by Russian gerontologist Vladimir Khavinson and colleagues, who investigated extremely short peptide sequences—often only a few amino acids long—and proposed that some could influence cellular activity and gene expression.
That makes bioregulators particularly interesting because the theory behind them isn’t simply:
peptide → receptor → biological response.
Instead, much of the research asks whether very short peptides can participate in the regulation of gene expression, protein synthesis, cellular aging, and tissue-specific biological processes.